Interestingly, the ANGPTL4‐treated groups [AP+ANGPTL4 and ANGPTL4 alone (4 mg/kg)] showed a reduced pancreatitis severity in the macrophage‐depleted groups compared with that of the macrophage WT groups, with decreased amylase and lipase levels (Fig 4A). The gene discussed is ANGPTL4; the disease is alkaline phosphatase measurement.